HUMAN METAPNEUOMOVIRUS (HMPV)

Clinical trials for HUMAN METAPNEUOMOVIRUS (HMPV) explained in plain language.

Never miss a new study

Get alerted when new HUMAN METAPNEUOMOVIRUS (HMPV) trials appear

Sign up with your email to follow new studies for HUMAN METAPNEUOMOVIRUS (HMPV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

One shot, two viruses? new mRNA vaccine targets RSV and hMPV

⭐️ VACCINE ⭐️ Not yet recruiting

This early-stage trial tests an experimental mRNA vaccine called mRNA-1365 in healthy adults aged 60 and older. The vaccine is designed to trigger immunity against two respiratory viruses—RSV and hMPV—which can cause severe illness in older people. Researchers will evaluate the v…

Matched conditions: HUMAN METAPNEUOMOVIRUS (HMPV)

Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Aug 15, 2026 00:00 UTC

HUMAN METAPNEUOMOVIRUS (HMPV)

Get alerted when new HUMAN METAPNEUOMOVIRUS (HMPV) trials appear

One shot, two viruses? new mRNA vaccine targets RSV and hMPV